REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/17/2026
Back to search
Official data from USPTO
TRIFERIC AVNU FERRIC PYROPHOSPHATE CITRATE INJECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/17/2026
Trademark type
Combined
Nice classes
5
Filing date
05/07/2020
Registration date
08/17/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/10/2021
First use in commerce
02/10/2021
Drawing code
3
Owner type
03
Owner location
Wixom, MI, US
Examiner
CHOSID-BROWN, ROBIN S
Law office
N10
Current location
TMO LAW OFFICE 119
Mark description
The mark consists of the words "TRIFERIC AVNU" in red capital letters above the words "ferric pyrophosphate citrate injection" in smaller, lower case gray letters. To the right of the literal element is a modified triangle shape, the inner field comprised of red and burgundy squares, with the smallest squares in blue.
Holders and representatives
Holders
ROCKWELL MEDICAL, INC.
Representatives
MATTHEW J. GIPSON PRICE HENEVELD LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
preparations for use in clinical and medical dialysis procedures; pharmaceutical solutions used in dialysis and hemodialysis; pharmaceutical preparationspreparations for treating iron deficiencyanemiakidney disease and renal disease; pharmaceutical preparations for injectionpreparations for treating iron deficiencyanemiakidney disease and renal disease; iron delivery therapycommercial iron nutritional supplementsintravenous fluids used for the delivery of iron and soluble ferric pyrophosphate; all goods containing ferric pyrophosphate citrate
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/15/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/14/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/23/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/21/2021
IUAF
USE AMENDMENT FILED
06/09/2021
EISU
TEAS STATEMENT OF USE RECEIVED
06/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/13/2021
PUBO
PUBLISHED FOR OPPOSITION
04/13/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/10/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/23/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2021
ALIE
ASSIGNED TO LIE
02/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/06/2020
GNRT
NON-FINAL ACTION E-MAILED
08/06/2020
CNRT
NON-FINAL ACTION WRITTEN
08/06/2020
DOCK
ASSIGNED TO EXAMINER
08/01/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2020
NWAP
NEW APPLICATION ENTERED
05/11/2020
Continuous trademark protection
Get notified about every new filing that threatens TRIFERIC AVNU FERRIC PYROPHOSPHATE CITRATE INJECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.